Pulmonary fibroblasts activated by the addition of TNF-α and IL-4 enhance lymphangiogenic capacity and ameliorate lung fibrosis in an allogeneic rat model

• Yuimi Matsuoka ,

  Roles Conceptualization, Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: yuimi@lymphogenix.com (YM), takahiro@lymphogenix.com (TI)

  Affiliations Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan, Research & Development Department, LYMPHOGENiX Ltd, Covent Garden, London, England, United Kingdom

  https://orcid.org/0009-0009-3560-2777

  ⨯
• Yuuki Shimizu,

  Roles Project administration, Writing – review & editing

  Affiliation Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

  https://orcid.org/0000-0003-3103-1160

  ⨯
• Koji Sakamoto,

  Roles Project administration, Writing – review & editing

  Affiliation Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Makoto Matsuyama,

  Roles Investigation

  Affiliation Department of Otorhinolaryngology, Juntendo University Faculty of Medicine,

  ⨯
• Toyoaki Murohara,

  Roles Supervision

  Affiliation Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

  ⨯
• Takahiro Iwamiya

  Roles Conceptualization, Supervision, Writing – review & editing

  * E-mail: yuimi@lymphogenix.com (YM), takahiro@lymphogenix.com (TI)

  Affiliations Research & Development Department, LYMPHOGENiX Ltd, Covent Garden, London, England, United Kingdom, Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan

  ⨯